Publikationen in Zusammenarbeit mit Forschern von Memorial Sloan Kettering Cancer Center (26)

2022

  1. NSCLC Subtyping in Conventional Cytology: Results of the International Association for the Study of Lung Cancer Cytology Working Group Survey to Determine Specific Cytomorphologic Criteria for Adenocarcinoma and Squamous Cell Carcinoma

    Journal of Thoracic Oncology, Vol. 17, Núm. 6, pp. 793-805

  2. Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib

    BMC Cancer, Vol. 22, Núm. 1

2021

  1. Live imaging of neolymphangiogenesis identifies acute antimetastatic roles of dsRNA mimics

    EMBO Molecular Medicine, Vol. 13, Núm. 12

  2. Psychological well-being of palliative care professionals: Who cares?

    Palliative and Supportive Care, Vol. 19, Núm. 2, pp. 257-261

  3. The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC

    Journal of Thoracic Oncology, Vol. 16, Núm. 4, pp. 686-696

2020

  1. A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

    Journal of Thoracic Oncology, Vol. 15, Núm. 10, pp. 1599-1610

  2. FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy

    EBioMedicine, Vol. 53

  3. IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy

    Journal of Thoracic Oncology, Vol. 15, Núm. 5, pp. 709-740

  4. PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee

    Journal of Thoracic Oncology, Vol. 15, Núm. 4, pp. 499-519

  5. The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee

    Journal of Thoracic Oncology, Vol. 15, Núm. 9, pp. 1409-1424

2019

  1. Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer

    Journal of Thoracic Oncology, Vol. 14, Núm. 3, pp. 377-407

  2. ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research

    Annals of Oncology, Vol. 30, Núm. 9, pp. 1417-1427

  3. FGFR1 Cooperates with EGFR in Lung Cancer Oncogenesis, and Their Combined Inhibition Shows Improved Efficacy

    Journal of Thoracic Oncology, Vol. 14, Núm. 4, pp. 641-655

  4. Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and BRAFV600E mutation

    Journal of Experimental Medicine, Vol. 216, Núm. 5, pp. 1061-1070

2017

  1. Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine

    Nature, Vol. 546, Núm. 7660, pp. 676-680

2016

  1. Lineage-specific roles of the cytoplasmic polyadenylation factor CPEB4 in the regulation of melanoma drivers

    Nature Communications, Vol. 7

2015

  1. Clinical, histopathologic, and genomic features of spitz tumors with ALK fusions

    American Journal of Surgical Pathology, Vol. 39, Núm. 5, pp. 581-591

  2. Cognitive and brain structural changes in a lung cancer population

    Journal of Thoracic Oncology, Vol. 10, Núm. 1, pp. 38-45

  3. Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and sézary syndrome: Effect of specific prognostic markers on survival and development of a prognostic model

    Journal of Clinical Oncology, Vol. 33, Núm. 32, pp. 3766-3773

  4. Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway

    Nature Genetics, Vol. 47, Núm. 10, pp. 1194-1199